ReviewF1000Research2019

Brexanolone, a neurosteroid antidepressant, vindicates the GABAergic deficit hypothesis of depression and may foster resilience.

Bernhard Lüscher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.